You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
2002, Volume 09, Issue 05, pages 245-304
CLINICAL ARTICLE
Br J Cardiol 2002;9:303-4
NICE announce audit of secondary prevention guidance
NICE announce audit of secondary prevention guidance Tom Quinn The National Institute for Clinical Excellence (NICE) has ann-ounced plans to commission the development of an...
CLINICAL ARTICLE
Br J Cardiol 2002;9:297-02
Optimising management of patients with hypertension and diabetes
Optimal management of hypertension and diabetes is essential if the cardiovascular and renal mortality and morbidity associated with this condition is to be reduced. Recent...
CLINICAL ARTICLE
Br J Cardiol 2002;9:294-6
Extensive multiple coronary artery to left ventricular fistulas – a 10-year case history
Extensive multiple coronary artery to left ventricular fistulas – a 10-year case history We report the 10-year case history of a 50-year-old woman who presented...
CLINICAL ARTICLE
Br J Cardiol 2002;9:291-3
Coarctation of the aorta: a life-long disease of the entire vascular system
Coarctation of the aorta is an important differential diagnosis in adults with hypertension. Unfortunately, simply removing the obstruction does not restore cardiovascular normality. Patients may...
CLINICAL ARTICLE
Br J Cardiol 2002;9:287-90
The use of echocardiography for stroke and peripheral embolus: is it time for British/European guidelines?
The American College of Cardiology and the American Heart Association recommend echocardiography in patients with stroke or peripheral embolus who are less than 45 years...
CLINICAL ARTICLE
Br J Cardiol 2002;9:280-6
Angiotensin II receptor antagonists in the treatment of heart failure: background to and design of the CHARM study
While angiotensin-converting enzyme (ACE) inhibitors are established agents for the treatment of hypertension and heart failure, in contrast the angiotensin II receptor antagonists (AIIRAs) have...
CLINICAL ARTICLE
Br J Cardiol 2002;9:273-9
Therapeutic potential of the natriuretic peptide system
Neurohormonal activation has a central role in the pathophysiology of various cardiovascular disorders. Despite recent therapeutic advances, potential exists to further manipulate these activated systems....
CLINICAL ARTICLE
Br J Cardiol 2002;9:265-72
The pathophysiology of primary pulmonary hypertension
Primary pulmonary hypertension (PPH) is a progressive disease with a poor prognosis. It is characterised by an elevated pulmonary artery pressure and pulmonary vascular resistance...
EDITORIAL
Br J Cardiol 2002;9:255-7
Garlic in cardiovascular disease – the last word?
Garlic has been used for its potential medicinal properties for centuries. It was cited 3,500 years ago by the Egyptians as useful in the treatment...
EDITORIAL
Br J Cardiol 2002;9:251-4
Unstable angina: the case for selective aggression
The prognosis for patients with non-ST elevation acute coronary syndromes (ACS) is not benign. Ongoing ischaemia is only one determinant of risk. The presence of...